C12N   1/00  \	0	0	4B065	C12N   1/00	424	ʪʪʸưʪХƥꥢޤϥ륹ʪޤޣˣ൯ʪޤޣˣ൯ʪޤޣˣʺٶݹޤϹʪĴ㡥˦說󡤣ˣˡʪޤϤʪݻޤ¸뤿ˡʪޤʪĴޤʬΥˡΤϡΣ	Microorganisms; Compositions thereof   (medicinal preparations containing material from protozoa, bacteria or viruses A61K0035660000, from algae A61K0036020000, from fungi A61K0036060000; preparing medicinal bacterial antigen or antibody compositions, e.g. bacterial vaccines, A61K0039000000); Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor[2006.01]
C12N   1/00  A	0	0	4B065	C12N   1/00	1036		Culture
C12N   1/00  B	0	1	4B065	C12N   1/00	925	ܾ㡥Уȡ١	Control of culture conditions (material supply conditions, pH, temperature)
C12N   1/00  C	0	2	4B065	C12N   1/00	168	̵	Control of ventilation conditions
C12N   1/00  D	0	3	4B065	C12N   1/00	116		Oxygen
C12N   1/00  E	0	1	4B065	C12N   1/00	74	ˢ	Defoaming
C12N   1/00  F	0	0	4B065	C12N   1/00	1165		Culture medium
C12N   1/00  G	0	1	4B065	C12N   1/00	728	ʬź	Addition of microingredients
C12N   1/00  H	0	1	4B065	C12N   1/00	18	ǥƥ顼֥륹	Disk tailor's solubles
C12N   1/00  J	0	0	4B065	C12N   1/00	83	Ϥλ	Sterilization of culture medium
C12N   1/00  K	0	0	4B065	C12N   1/00	281	ʪν	Treatment of culture
C12N   1/00  L	0	0	4B065	C12N   1/00	179	ʪ	Micro-organism cell body
C12N   1/00  M	0	1	4B065	C12N   1/00	101	󥰥륻ץƥΣӣãС	SCP
C12N   1/00  N	0	0	4B065	C12N   1/00	359	ʪΤβù	Processing of micro-organism cell body
C12N   1/00  P	0	0	4B065	C12N   1/00	706	ʪ	Use of microorganisms
C12N   1/00  Q	0	1	4B065	C12N   1/00	164	̵	Safening of gas
C12N   1/00  R	0	1	4B065	C12N   1/00	634	ͭʪʬ	Decomposition of hazardous substances
C12N   1/00  S	0	1	4B065	C12N   1/00	933	ͭʪؤѡѿãơã	Use in organic waste (waste water R C 02 F, fertiliser R C 05)
C12N   1/00  T	0	0	4B065	C12N   1/00	367	ʪΥ꡼˥	Screening of micro-organisms
C12N   1/00  U	0	0	4B065	C12N   1/00	448	ҹشط	Related to genetic engineering
C12N   1/00  Z	0	0	4B065	C12N   1/00	394	¾	Others
C12N   1/02  \	1	1	4B065	C12N   1/02	1126	ϤʪʬΥΣ	Separating microorganisms from their culture media[2006.01]
C12N   1/04  \	1	1	4B065	C12N   1/04	1184	ʪ¸ݻʸ경ʪãΣˡΣ	Preserving or maintaining viable microorganisms (immobilised microorganisms C12N0011000000)[2006.01]
C12N   1/06  \	1	1	4B065	C12N   1/06	217	ʪϲΣ	Lysis of microorganisms[2026.01]
C12N   1/063  \	2	2	4B065	C12N   1/063	31	ΡΣ	of yeast[2026.01]
C12N   1/066  \	2	2	4B065	C12N   1/066	52	ʪŪΣ	by physical processes[2026.01]
C12N   1/08  \	1	1	4B065	C12N   1/08	69	˻̤θΣ	Reducing the nucleic acid content[2006.01]
C12N   1/10  \	1	1	4B065	C12N   1/10	193	ưʪΤϡΣ	Protozoa; Culture media therefor[2026.01]
C12N   1/105  \	2	2	4B065	C12N   1/105	30	ưʪñΥΡΣ	Protozoal isolates[2026.01]
C12N   1/11  \	2	2	4B065	C12N   1/11	144	ʪƳˤäƽ줿ΡΣ	modified by introduction of foreign genetic material[2006.01]
C12N   1/12  \	1	1	4B065	C12N   1/12	305	ñ˦ࡨΤϡʿʿʪȣˡΣ	Unicellular algae; Culture media therefor (as new plants A01H0013000000)[2026.01]
C12N   1/12  A	1	0	4B065	C12N   1/12	1058		Culture
C12N   1/12  B	1	0	4B065	C12N   1/12	210		Culture medium
C12N   1/12  Z	1	0	4B065	C12N   1/12	342	¾	Others
C12N   1/125  \	2	2	4B065	C12N   1/125	499	ñ˦ñΥΡΣ	Unicellular algae isolates[2026.01]
C12N   1/13  \	2	2	4B065	C12N   1/13	580	ʪƳˤäƽ줿ΡΣ	modified by introduction of foreign genetic material[2006.01]
C12N   1/14  \	1	1	4B065	C12N   1/14	986	ʤΤκݣǣʿʪȣˡΤϡΣ	Fungi (culture of mushrooms A01G0018000000;as new plants A01H0015000000); Culture media therefor[2026.01]
C12N   1/14  J	1	0	4B065	C12N   1/14	864		Cultivation
C12N   1/14  K	1	0	4B065	C12N   1/14	687		Culture media
C12N   1/14  Z	1	0	4B065	C12N   1/14	173	¾	Others
C12N   1/14 101 \	2	2	4B065	C12N   1/14	675	ŪˡʰŪ֣ãͣ	General koji making methods (general koji making devices C 12 M 1/16)
C12N   1/145  \	2	2	4B065	C12N   1/145	0	ñΥΡΣ	Fungi isolates[2026.01]
C12N   1/15  \	2	2	4B065	C12N   1/15	27897	ʪƳˤäƽ줿ΡΣ	modified by introduction of foreign genetic material[2006.01]
C12N   1/16  \	2	2	4B065	C12N   1/16	804	졨ΤϡΣ	Yeasts; Culture media therefor[2026.01]
C12N   1/16  A	2	0	4B065	C12N   1/16	457		Culture
C12N   1/16  B	2	1	4B065	C12N   1/16	135	ܾ	Control of culture conditions
C12N   1/16  C	2	2	4B065	C12N   1/16	25	̵	Control of ventilation conditions
C12N   1/16  D	2	0	4B065	C12N   1/16	208		Culture medium
C12N   1/16  E	2	1	4B065	C12N   1/16	127	úǸ	Use of specific carbon source
C12N   1/16  F	2	1	4B065	C12N   1/16	104	ʬź	Addition of microingredients
C12N   1/16  H	2	0	4B065	C12N   1/16	100	Τ¸	Storage of saccharomycete body
C12N   1/16  J	2	0	4B065	C12N   1/16	369	Τβù	Processing saccharomycete body
C12N   1/16  Z	2	0	4B065	C12N   1/16	254	¾	Others
C12N   1/165  \	3	3	4B065	C12N   1/165	0	ñΥΡΣ	Yeast isolates[2026.01]
C12N   1/18  \	3	3	4B065	C12N   1/18	408	ѥ졨ӡΣ	Baker's yeast; Brewer's yeast[2026.01]
C12N   1/185  \	4	4	4B065	C12N   1/185	0	åߥñΥΡΣ	Saccharomyces isolates[2026.01]
C12N   1/19  \	3	3	4B065	C12N   1/19	30910	ʪƳˤäƽ줿ΡΣ	modified by introduction of foreign genetic material[2006.01]
C12N   1/20  \	1	1	4B065	C12N   1/20	5039	ٶݡΤϡΣ	Bacteria; Culture media therefor[2026.01]
C12N   1/20  B	1	0	4B065	C12N   1/20	264	ٶݤ¸	Storage of bacteria
C12N   1/20  C	1	0	4B065	C12N   1/20	449	ٶݤβù	Processing of bacteria
C12N   1/20  D	1	0	4B065	C12N   1/20	1630	Ķ˴ؤΡʬˤΤϣãΣƤͿ	Related to environmental conservation (add F is decomposition is used)
C12N   1/20  E	1	0	4B065	C12N   1/20	2658	ưʪʪޡͭʪޤޤͶޡޤϿʪĹĴ	Feed, pharmaceuticals, animal pharmaceuticals, biocides, rejectants or attractants for hazardous animals, or plant growth adjusters
C12N   1/20  F	1	0	4B065	C12N   1/20	1647	ٶݤˤʬ	Decomposition by bacteria
C12N   1/20  G	1	0	4B065	C12N   1/20	1069		Cultivation
C12N   1/20  H	1	0	4B065	C12N   1/20	0		Culture media
C12N   1/20  Z	1	0	4B065	C12N   1/20	549	¾	Others
C12N   1/205  \	2	2	4B065	C12N   1/205	0	ٶñΥΡΣ	Bacterial isolates[2026.01]
C12N   1/21  \	2	2	4B065	C12N   1/21	38649	ʪƳˤäƽ줿ΡΣ	modified by introduction of foreign genetic material[2006.01]
C12N   1/22  \	1	1	4B065	C12N   1/22	115	ޤϤβÿʬʪˡޤϤޤϡΣ	Processes using, or culture media containing, cellulose or hydrolysates thereof[2006.01]
C12N   1/24  \	1	1	4B065	C12N   1/24	19	βѱդˡޤϤޤϡΣ	Processes using, or culture media containing, waste sulfite liquor[2006.01]
C12N   1/26  \	1	1	4B065	C12N   1/26	209	úǤˡޤϤޤϡʪѤúãǣˡΣ	Processes using, or culture media containing, hydrocarbons (refining of hydrocarbon oils by using microorganisms C10G0032000000)[2006.01]
C12N   1/28  \	2	2	4B065	C12N   1/28	54	²ΤΡΣ	aliphatic[2006.01]
C12N   1/30  \	3	3	4B065	C12N   1/30	9	úǸңİʲΤΡΣ	having five or less carbon atoms[2006.01]
C12N   1/32  \	1	1	4B065	C12N   1/32	291	饢륫Ρ롤ʤããΤΤѤޤϤޤϡΣ	Processes using, or culture media containing, lower alkanols, i.e. C1 to C6[2006.01]
C12N   1/34  \	1	1	4B065	C12N   1/34	21	ˢϤѤˡΣ	Processes using foam culture[2006.01]
C12N   1/36  \	1	1	4B065	C12N   1/36	23	˦ŬޤಽΣ	Adaptation or attenuation of cells[2006.01]
C12N   1/38  \	1	1	4B065	C12N   1/38	846	ɬܤҤǤʤʪźäˤޤϳβŪɷ㡨ʪνˤλɷʣãΣͥˡΣ	Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound (C12N0001340000 takes precedence)[2006.01]
C12N   3/00  \	0	0	4B065	C12N   3/00	70	˦ҤηޤʬΥˡΣ	Spore-forming or isolating processes [3]
C12N   5/00  \	0	0	4B065	C12N   5/00	3517	ҥȡưʪޤϿʪκ˦㡥饤ȿܤޤϰݻΤϡȿܵѤˤ뿢ʪȣˡΣ	Undifferentiated animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (multiplication od plant by tissue culture technique A01H4/00) [3, 5]
C12N   5/02  \	1	1	4B065	C12N   5/02	1274	ˤñޤʣκ˦ΰݻΤϡΣ	Propagation of single cells or cells in suspension; Maintenance thereof; Culture media therefor [3]
C12N   5/04  \	1	1	4B065	C12N   5/04	1789	ʪ˦ޤȿΣ	Plant cells or tissues [5]
C12N   5/07  \	1	1	4B065	C12N   5/07	1955	ưʪ˦ޤȿΣ	Animal cells or tissues [2010.01]
C12N   5/071  \	2	2	4B065	C12N   5/071	9192	ưʪ˦ޤȿ㡥ҥȺ˦ޤȿΣ	Vertebrate cells or tissues, e.g. human cells or tissues [2010.01]
C12N   5/073  \	3	3	4B065	C12N   5/073	868	˦ޤȿۻ˦ޤȿΣ	Embryonic cells or tissues; Foetal cells or tissues [2010.01]
C12N   5/0735  \	4	4	4B065	C12N   5/0735	2891	˦˦Σ	Embryonic stem cells; Embryonic germ cells [2010.01]
C12N   5/074  \	3	3	4B065	C12N   5/074	3158	δ˦Σ	Adult stem cells [2010.01]
C12N   5/075  \	3	3	4B065	C12N   5/075	279	˦񸶺˦Σ	Oocytes; Oogonia [2010.01]
C12N   5/076  \	3	3	4B065	C12N   5/076	324	˦˦Σ	Sperm cells; Spermatogonia [2010.01]
C12N   5/077  \	3	3	4B065	C12N   5/077	2831	պ˦㡥˦˦ּ˦ú˦ޤ϶˦Σ	Mesenchymal cells, e.g. bone cells, cartilage cells, marrow stromal cells, fat cells or muscle cells [2010.01]
C12N   5/0775  \	4	4	4B065	C12N   5/0775	2765	շϴ˦ȿͳ贴˦Σ	Mesenchymal stem cells; Adipose-tissue derived stem cells [2010.01]
C12N   5/078  \	3	3	4B065	C12N   5/078	2402	դޤȱַϤκ˦Σ	Cells from blood or from the immune system [2010.01]
C12N   5/0781  \	4	4	4B065	C12N   5/0781	808	º˦˦Σ	B cells; Progenitors thereof [2010.01]
C12N   5/0783  \	4	4	4B065	C12N   5/0783	5500	Ժ˦Σ˺˦Ժ˦ϣΣ˺˦˦Σ	T cells; NK cells; Progenitors of T or NK cells [2010.01]
C12N   5/0784  \	4	4	4B065	C12N   5/0784	1096	˦˦Σ	Dendritic cells; Progenitors thereof [2010.01]
C12N   5/0786  \	4	4	4B065	C12N   5/0786	1012	ñ塨ޥեΣ	Monocytes; Macrophages [2010.01]
C12N   5/0787  \	4	4	4B065	C12N   5/0787	248	γ塤㡥塤塤塤˦Σ	Granulocytes, e.g. basophils, eosinophils, neutrophils or mast cells [2010.01]
C12N   5/0789  \	4	4	4B065	C12N   5/0789	2070	˦¿ǽ˦Σ	Stem cells; Multipotent progenitor cells [2010.01]
C12N   5/079  \	3	3	4B065	C12N   5/079	690	зϤκ˦Σ	Neural cells [2010.01]
C12N   5/0793  \	4	4	4B065	C12N   5/0793	906	к˦Σ	Neurons [2010.01]
C12N   5/0797  \	4	4	4B065	C12N   5/0797	919	˦˦Σ	Stem cells; Progenitor cells [2010.01]
C12N   5/09  \	1	1	4B065	C12N   5/09	2364	˦Σ	Tumour cells [2010.01]
C12N   5/095  \	2	2	4B065	C12N   5/095	324	˦˦Σ	Stem cells; Progenitor cells [2010.01]
C12N   5/10  \	1	1	4B065	C12N   5/10	51641	ʪƳˤäƽ줿˦㡥륹ž˦Σ	Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells [5]
C12N   5/12  \	2	2	4B065	C12N   5/12	1610	ͻ˦㡥ϥ֥ɡޡΣ	Fused cells, e.g. hybridomas [5]
C12N   5/14  \	3	3	4B065	C12N   5/14	233	ʪ˦Σ	Plant cells [5]
C12N   5/16  \	3	3	4B065	C12N   5/16	1396	ưʪ˦Σ	Animal cells [5]
C12N   5/18  \	4	4	4B065	C12N   5/18	220	ͥߺ˦㡥ޥ˦Σ	Murine cells, e.g. mouse cells [5]
C12N   5/20  \	5	5	4B065	C12N   5/20	3504	ͻѡȥʡΰ¥ѵǤΡΣ	one of the fusion partners being a B lymphocyte [5]
C12N   5/22  \	3	3	4B065	C12N   5/22	185	ҥȺ˦Σ	Human cells [5]
C12N   5/24  \	4	4	4B065	C12N   5/24	297	ͻѡȥʡΰ¥ѵǤΡΣ	one of the fusion partners being a B lymphocyte [5]
C12N   5/26  \	3	3	4B065	C12N   5/26	127	ۼͻˤ˦Σ	Cells resulting from interspecies fusion [5]
C12N   5/28  \	4	4	4B065	C12N   5/28	119	ͻѡȥʡΰҥȺ˦ǤΡΣ	one of the fusion partners being a human cell [5]
C12N   7/00  \	0	0	4B065	C12N   7/00	4183	륹㡥ХƥꥪեޤʪĴޤʥ륹ޤޣˣѥ륹ޤϹʪĴ㡥륹說󡤣ˣˡΣ	Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (medicinal preparations containing viruses A61K0035760000;preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K0039000000)[2006.01]
C12N   7/01  \	1	1	4B065	C12N   7/01	6357	ʪƳˤäƽ줿륹㡥Хƥꥪեʥ٥ãΣˡΣ	Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material(vectors C12N15/00) [5]
C12N   7/02  \	1	1	4B065	C12N   7/02	904	ޤΣ	Recovery or purification [3]
C12N   7/04  \	1	1	4B065	C12N   7/04	1335	Գ貽ޤϼǲ륹֥˥åȤΣ	Inactivation or attenuation; Producing viral sub-units [3]
C12N   7/06  \	2	2	4B065	C12N   7/06	240	ŪˤΡΣ	by chemical treatment [3]
C12N   7/08  \	2	2	4B065	C12N   7/08	83	륹ηܼˤΡΣ	by serial passage of virus [3]
C12N   9/00  \	0	0	4B050	C12N   9/00	3388	ǡ㡥ꥬʣˡΡʪʻѹǴͭޣˣѣѹǤޤϹޣˣǴͭޣãġˡǤĴ˳ʬΥޤˡΣ	Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof (preparations containing enzymes for cleaning teeth A61K0008660000, A61Q0011000000;medicinal preparations containing enzymes or proenzymes A61K0038430000;enzyme containing detergent compositions C11D); Processes for preparing, activating, inhibiting, separating, or purifying enzymes[2006.01]
C12N   9/02  \	1	1	4B050	C12N   9/02	3360	Ըǡʣˡ㡥륷ե顼Σ	Oxidoreductases (1.), e.g. luciferase [3]
C12N   9/04  \	2	2	4B050	C12N   9/04	797	ŻҶͿΤȤƤΣãȣϣȴ˺ѤΡ㡥륳æǹǡʣˡΣ	acting on CHOH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1) [3]
C12N   9/04  D	2	0	4B050	C12N   9/04	510	륳	Oxidizing glucose
C12N   9/04  Z	2	0	4B050	C12N   9/04	1651	¾Τ	Others
C12N   9/06  \	2	2	4B050	C12N   9/06	352	ŻҶͿΤȤƤǴͭʪ˺ѤΡʣˡΣ	acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7) [3]
C12N   9/06  A	2	0	4B050	C12N   9/06	94	ꥫ	Uricase
C12N   9/06  Z	2	0	4B050	C12N   9/06	776	¾Τ	Others
C12N   9/08  \	2	2	4B050	C12N   9/08	485	ŻҼΤȤƤβǤ˺ѤΡʣˡΣ	acting on hydrogen peroxide as acceptor (1.11) [3]
C12N   9/10  \	1	1	4B050	C12N   9/10	3954	žܹǡʣˡʥܥ̥쥢ãΣˡΣ	Transferases (2.) (ribonucleases C12N 9/22) [3]
C12N   9/12  \	2	2	4B050	C12N   9/12	3035	ͭžܤΡ㡥ʡʣˡΣ	transferring phosphorus containing groups, e.g. kinases (2.7) [3]
C12N   9/14  \	1	1	4B050	C12N   9/14	1186	ÿʬǡʣˡΣ	Hydrolases (3.) [3]
C12N   9/16  \	2	2	4B050	C12N   9/16	748	ƥ˺ѤΡʣˡΣ	acting on ester bonds (3.1) [3]
C12N   9/16  B	2	0	4B050	C12N   9/16	770	եե	Phosphatase
C12N   9/16  Z	2	0	4B050	C12N   9/16	2768	¾ΤΡ㡥ǥܥ̥쥢	Others, e.g. exodeoxyribonuclease
C12N   9/18  \	3	3	4B050	C12N   9/18	502	ܥƥÿʬǡΣ	Carboxylic ester hydrolases [3]
C12N   9/20  \	4	4	4B050	C12N   9/20	1102	ȥꥰꥻɤʬ㡥ѡˤΡΣ	Triglyceride splitting, e.g. by means of lipase [3]
C12N   9/22  \	3	3	4B050	C12N   9/22	970	ܥ̥쥢Σ	Ribonucleases [3]
C12N   9/24  \	2	2	4B050	C12N   9/24	1716	ꥳ벽ʪ˺ѤΡʣˡΣ	acting on glycosyl compounds (3.2) [3]
C12N   9/26  \	3	3	4B050	C12N   9/26	486	륳ɷ˺ѤΡ㡥ҥ˥٥륿ߥ顼Σ	acting on alpha-1, 4-glucosidic bonds, e.g. hyaluronidase, invertase, amylase [3]
C12N   9/26  A	3	0	4B050	C12N   9/26	509	ߥ顼ࡤ㡥¡ݥߥ顼	Amylase (b-amylase)
C12N   9/26  Z	3	0	4B050	C12N   9/26	411	¾Τ	Others
C12N   9/28  \	4	4	4B050	C12N   9/28	463	ʪΦߥ顼㡥ٶݥߥ顼Σ	Alpha-amylase from microbial source, e.g. bacterial amylase [3]
C12N   9/30  \	5	5	4B050	C12N   9/30	157	൯ΤΡΣ	Fungal source [3]
C12N   9/32  \	4	4	4B050	C12N   9/32	18	ʪΦߥ顼Σ	Alpha-amylase from plant source [3]
C12N   9/34  \	4	4	4B050	C12N   9/34	217	륳ߥ顼Σ	Glucoamylase [3]
C12N   9/36  \	3	3	4B050	C12N   9/36	321	Ρߥȣ륢ߥΡǥġ륳֤Φ¡˺ѤΡ㡥꥾Σ	acting on beta-1, 4 bonds between N-acetylmuramic acid and 2-acetylamino 2-deoxy-D-glucose, e.g. lysozyme [3]
C12N   9/38  \	3	3	4B050	C12N   9/38	361	¡饯ȡꥳɷ˺ѤΡ㡥¡饯ȥΣ	acting on beta-galactose-glycoside bonds, e.g. beta-galactosidase [3]
C12N   9/40  \	3	3	4B050	C12N   9/40	216	饯ȡꥳɷ˺ѤΡ㡥饯ȥΣ	acting on alpha-galactose-glycoside bonds, e.g. alpha-galactosidase [3]
C12N   9/42  \	3	3	4B050	C12N   9/42	1618	¡륳ɷ˺ѤΡ㡥顼Σ	acting on beta-1, 4-glucosidic bonds, e.g. cellulase [3]
C12N   9/44  \	3	3	4B050	C12N   9/44	292	륳ɷ˺ѤΡ㡥ߥ顼ץʡΣ	acting on alpha-1, 6-glucosidic bonds, e.g. isoamylase, pullulanase [3]
C12N   9/46  \	4	4	4B050	C12N   9/46	50	ǥȥʡΣ	Dextranase [3]
C12N   9/48  \	2	2	4B050	C12N   9/48	735	ڥץɷ˺ѤΡ㡥ȥܥץ饹󡤥󥢥ߥΥڥץʣˡΣ	acting on peptide bonds, e.g. thromboplastin, leucine aminopeptidase (3.4) [3]
C12N   9/50  \	3	3	4B050	C12N   9/50	1368	ץƥʡΣ	Proteinases [3]
C12N   9/52  \	4	4	4B050	C12N   9/52	739	ٶݤФ줿ΡΣ	derived from bacteria [3]
C12N   9/54  \	5	5	4B050	C12N   9/54	536	ٶݤХ륹°ǤΡΣ	bacteria being Bacillus [3]
C12N   9/56  \	6	6	4B050	C12N   9/56	318	Х륹֥륹ޤϥХ륹ꥱ˥եߥΣ	Bacillus subtilis or Bacillus licheniformis [3]
C12N   9/58  \	4	4	4B050	C12N   9/58	260	फФ줿ΡΣ	derived from fungi [3]
C12N   9/60  \	5	5	4B050	C12N   9/60	79	줫ΤΡΣ	from yeast [3]
C12N   9/62  \	5	5	4B050	C12N   9/62	205	ڥ륮륹°ΤΡΣ	from Aspergillus [3]
C12N   9/64  \	4	4	4B050	C12N   9/64	645	ưʪȿФ줿Ρ㡥˥Σ	derived from animal tissue, e.g. rennin [3]
C12N   9/64  A	4	0	4B050	C12N   9/64	99	ꥯ쥤	Kallikrein
C12N   9/64  Z	4	0	4B050	C12N   9/64	1107	¾Τ	Others
C12N   9/66  \	3	3	4B050	C12N   9/66	131	饹Σ	Elastase [3]
C12N   9/68  \	3	3	4B050	C12N   9/68	131	ץ饹ߥ󡤤ʤե֥ΥꥷΣ	Plasmin, i.e. fibrinolysin [3]
C12N   9/70  \	3	3	4B050	C12N   9/70	43	ȥץȥʡΣ	Streptokinase [3]
C12N   9/72  \	3	3	4B050	C12N   9/72	375	ʡΣ	Urokinase [3]
C12N   9/74  \	3	3	4B050	C12N   9/74	132	ȥӥΣ	Thrombin [3]
C12N   9/76  \	3	3	4B050	C12N   9/76	166	ȥץ󡨥ȥץΣ	Trypsin; Chymotrypsin [3]
C12N   9/78  \	2	2	4B050	C12N   9/78	525	ڥץɷʳΣáη˺ѤΡʣˡΣ	acting on carbon to nitrogen bonds other than peptide bonds (3.5) [3]
C12N   9/80  \	3	3	4B050	C12N   9/80	337	ߥɤΥߥɷ˺ѤΡΣ	acting on amide bonds in linear amides [3]
C12N   9/82  \	4	4	4B050	C12N   9/82	110	ѥ饮ʡΣ	Asparaginase [3]
C12N   9/84  \	4	4	4B050	C12N   9/84	48	ڥ˥󥢥ߥΣ	Penicillin amidase [3]
C12N   9/86  \	3	3	4B050	C12N   9/86	151	ľߥɤΥߥɷ˺ѤΡ㡥ڥ˥ʡΣ	acting on amide bonds in cyclic amides, e.g. penicillinase [3]
C12N   9/88  \	1	1	4B050	C12N   9/88	1804	ղùǡʣˡΣ	Lyases (4.) [3]
C12N   9/90  \	1	1	4B050	C12N   9/90	783	ǡʣˡΣ	Isomerases (5.) [3]
C12N   9/92  \	2	2	4B050	C12N   9/92	168	륳顼Σ	Glucose isomerase [3]
C12N   9/94  \	1	1	4B050	C12N   9/94	23	ѥ󥯥쥢Σ	Pancreatin [3]
C12N   9/96  \	1	1	4B050	C12N   9/96	1159	ղΤޤʪ뤳ȤˤǤΰ경ΤΣ	Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates [3]
C12N   9/98  \	1	1	4B050	C12N   9/98	258	γޤϼͳήưʪĴʣãΣͥˡΣ	Preparation of granular or free-flowing enzyme compositions (C12N 9/96 takes precedence) [3]
C12N   9/99  \	1	1	4B050	C12N   9/99	5683	ؽˤǤԳΣ	Enzyme inactivation by chemical treatment [3]
C12N  11/00  \	0	0	4B033	C12N  11/00	1000	ôηޤϸ경ǡôηޤϸ경ʪĴΣ	Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
C12N  11/02  \	1	1	4B033	C12N  11/02	980	ͭôξޤ˸경Ǥޤʪ˦Σ	Enzymes or microbial cells immobilised on or in an organic carrier
C12N  11/04  \	2	2	4B033	C12N  11/04	781	ô礵줿Ρ㡥ޤݡΣ	entrapped within the carrier, e.g. gel or hollow fibres
C12N  11/06  \	2	2	4B033	C12N  11/06	246	ͶˤäôΤȷ礷ΡΣ	attached to the carrier via a bridging agent
C12N  11/08  \	2	2	4B033	C12N  11/08	752	ôΤʬҤǤΡΣ	the carrier being a synthetic polymer [2020.01]
C12N  11/082  \	3	3	4B033	C12N  11/082	358	úǡú˰·ΤߤͿȿˤä줿ΡΣ	obtained by reactions only involving carbon-to-carbon unsaturated bonds [2020.01]
C12N  11/084  \	4	4	4B033	C12N  11/084	272	ӥ˥륢륳ñ̤ͭŹΡΣ	Polymers containing vinyl alcohol units [2020.01]
C12N  11/087  \	4	4	4B033	C12N  11/087	359	ŹΡΣ	Acrylic polymers [2020.01]
C12N  11/089  \	3	3	4B033	C12N  11/089	117	úǡú˰·ΤߤͿȿʳȿˤä줿ΡΣ	obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [2020.01]
C12N  11/091  \	4	4	4B033	C12N  11/091	45	եΡ顨ߥμΣ	Phenol resins; Amino resins [2020.01]
C12N  11/093  \	4	4	4B033	C12N  11/093	107	ݥꥦ쥿Σ	Polyurethanes [2020.01]
C12N  11/096  \	4	4	4B033	C12N  11/096	112	ݥꥨƥ롨ݥꥢߥɡΣ	Polyesters; Polyamides [2020.01]
C12N  11/098  \	3	3	4B033	C12N  11/098	306	Ǥޤʪ˦¸߲Ƿ줿ΡΣ	formed in the presence of the enzymes or microbial cells [2020.01]
C12N  11/10  \	2	2	4B033	C12N  11/10	521	ôΤú岽ʪǤΡΣ	the carrier being a carbohydrate
C12N  11/12  \	3	3	4B033	C12N  11/12	293	ޤϤͶƳΡΣ	Cellulose or derivatives thereof
C12N  11/14  \	1	1	4B033	C12N  11/14	1130	̵ôξޤ˸경Ǥޤʪ˦Σ	Enzymes or microbial cells immobilised on or in an inorganic carrier
C12N  11/16  \	1	1	4B033	C12N  11/16	124	ʪ˦ޤ˸경Ǥޤʪ˦Σ	Enzymes or microbial cells immobilised on or in a biological cell
C12N  11/18  \	1	1	4B033	C12N  11/18	69	ʣǷϡΣ	Multi-enzyme systems
C12N  13/00  \	0	0	4B033	C12N  13/00	824	ʪޤϹǤŵޤưͥ륮ˤ㡥ȡΣ	Treatment of micro-organisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves [3]
C12N  15/00  \	0	0	4B024	C12N  15/00	8354	Ѱۤޤϰҹءҹؤ˴ؤģΣޤϣңΣ٥㡥ץ饹ߥɡޤϤʬΥ¤ޤΤνɼλѡѰΤޤϰŪ˽줿ʪãΣãΣãΣʪȡȿܵѤˤ뿢ʪȣưʪˣҼ¤μŤΤΤκ˦ʪͭޤλѡҼţˣڥץɰ̣ãˡˡΣ	Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (mutants or genetically engineered microorganisms C12N1/00, C12N5/00, C12N7/00; new plants A01H; plant reproduction by tissue culture techniques A01H4/00; new animals A01K67/00; use of medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases, gene therapy A61K48/00; peptides in general C07K) [3, 5, 6]
C12N  15/00 100 \	1	1	4B024	C12N  15/00	1	ߡƣɣãΣФꤹ뤿ΥߡƣɡڿͿߡ	Dummy fI for setting up dummy fIC12N15/00 100@P [stop new assigment]
C12N  15/00 100 P	1	0	4B024	C12N  15/00	239	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/00 is assigned [stop new assigment]
C12N  15/00 100 Z	1	0	4B024	C12N  15/00	80	¾	Others
C12N  15/01  \	1	1	4B024	C12N  15/01	8	ʪƳʤѰΤĴΤΥ꡼˥ˡΣ	Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor [5]
C12N  15/01  P	1	0	4B024	C12N  15/01	157	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/01 is assigned [stop new assigment]
C12N  15/01  Z	1	0	4B024	C12N  15/01	834	¾	Others
C12N  15/02  \	1	1	4B024	C12N  15/02	5	İʾκ˦ͻˤͻ˦Ĵ㡥ץȥץ饹ͻΣ	Preparation of hybrid cells by fusion of two or more cells, e.g. protoplast fusion [5]
C12N  15/02  P	1	0	4B024	C12N  15/02	20	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/02 is assigned [stop new assigment]
C12N  15/02  Z	1	0	4B024	C12N  15/02	66	¾	Others
C12N  15/03  \	2	2	4B024	C12N  15/03	1	ٶݡΣ	Bacteria [5]
C12N  15/03  P	2	0	4B024	C12N  15/03	24	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/03 is assigned [stop new assigment]
C12N  15/03  Z	2	0	4B024	C12N  15/03	40	¾	Others
C12N  15/04  \	2	2	4B024	C12N  15/04	2	Σ	Fungi [5]
C12N  15/04  P	2	0	4B024	C12N  15/04	47	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/04 is assigned [stop new assigment]
C12N  15/04  Z	2	0	4B024	C12N  15/04	43	¾	Others
C12N  15/05  \	2	2	4B024	C12N  15/05	16	ʪ˦Σ	Plant cells [5]
C12N  15/06  \	2	2	4B024	C12N  15/06	118	ưʪ˦Σ	Animal cells [5]
C12N  15/06 100 \	3	3	4B024	C12N  15/06	802	Υʥ빳Τ˴ؤ	related to monoclonal antibody
C12N  15/07  \	2	2	4B024	C12N  15/07	23	ҥȺ˦Σ	Human cells [5]
C12N  15/07 100 \	3	3	4B024	C12N  15/07	35	Υʥ빳Τ˴ؤ	related to monoclonal antibody
C12N  15/08  \	2	2	4B024	C12N  15/08	15	ۼ֤ͻˤ˦Σ	Cells resulting from interspecies fusion [5]
C12N  15/08 100 \	3	3	4B024	C12N  15/08	63	Υʥ빳Τ˴ؤ	related to monoclonal antibody
C12N  15/09  \	1	1	4B024	C12N  15/09	411	ȴģΣѡΣ	Recombinant DNA-technology [5]
C12N  15/09  P	1	0	4B024	C12N  15/09	1238	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/09 is assigned [stop new assigment]
C12N  15/09  Z	1	0	4B024	C12N  15/09	10036	¾	Others
C12N  15/09 100 \	2	2	4B024	C12N  15/09	1640	ΥԽѡ㡥ԣ̣ţΡ󥯥ե󥬡̥쥢Ѥ	Genome editing technology, e.g. using TALEN, zinc finger nuclease
C12N  15/09 110 \	3	3	4B024	C12N  15/09	3166	ãңɣӣУҡãѤ	using CRIsPR/Cas
C12N  15/09 200 \	2	2	4B024	C12N  15/09	4859	ģΣåסޥ쥤	DNA chip, microarray
C12N  15/10  \	2	2	4B024	C12N  15/10	46	ģΣޤϣңΣʬΥ¤ޤΤˡʣģΣޤϣңΣβŪ¤ãȣʪΤޤϹǤѤ¤ݥ̥쥪ɤ¤ãУˡΣ	Processes for the isolation, preparation or purification of DNA or RNA (chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34) [5]
C12N  15/10  P	2	0	4B024	C12N  15/10	2079	ѥƥȥեߥ꡼ˣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/10, C12N15/1034, C12N15/1037, C12N15/1041, C12N15/1044, C12N15/1048, C12N15/1051, C12N15/1055, C12N15/1058, C12N15/1062, C12N15/1065, C12N15/1068, C12N15/1072, C12N15/1075, C12N15/1079, C12N15/1082, C12N15/1086, C12N15/1089, C12N15/1093, C12N15/1096 are assigned [stop new assigment]
C12N  15/10  Z	2	0	4B024	C12N  15/10	3156	¾	Others
C12N  15/10 100 \	3	3	4B024	C12N  15/10	14	ʪγ˻ФޤʬΥ㡥ʬΥޤñΥˡΤξ˾ױ	Extraction or separation of nucleic acids from biological samples, e.g. pure separation or isolation method; conditions, buffer solutions therefore
C12N  15/10 100 P	3	0	4B024	C12N  15/10	316	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1003 is assigned [stop new assigment]
C12N  15/10 100 Z	3	0	4B024	C12N  15/10	949	¾	Others
C12N  15/10 110 \	4	4	4B024	C12N  15/10	5	ݻôΤˤΡ㡥γҡݥޡ	by solid support carrier, e.g. particles, polymer
C12N  15/10 110 P	4	0	4B024	C12N  15/10	285	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1006 is assigned [stop new assigment]
C12N  15/10 110 Z	4	0	4B024	C12N  15/10	616	¾	Others
C12N  15/10 112 \	5	5	4B024	C12N  15/10	1	ޥȥեˤΡ㡥ŵư򴹡	by chromatography, e.g. electrophoresis, ion-exchange, reversed-phase
C12N  15/10 112 P	5	0	4B024	C12N  15/10	131	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/101 is assigned [stop new assigment]
C12N  15/10 112 Z	5	0	4B024	C12N  15/10	259	¾	Others
C12N  15/10 114 \	5	5	4B024	C12N  15/10	0	ӡλѤˤ	by using magnetic beads
C12N  15/10 114 P	5	0	4B024	C12N  15/10	93	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1013 is assigned [stop new assigment]
C12N  15/10 114 Z	5	0	4B024	C12N  15/10	253	¾	Others
C12N  15/10 120 \	4	4	4B024	C12N  15/10	0	ˤΡ㡥եåȡλ	by filteration, e.g. using filters, frits, membranes
C12N  15/10 120 P	4	0	4B024	C12N  15/10	122	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1017 is assigned [stop new assigment]
C12N  15/10 120 Z	4	0	4B024	C12N  15/10	202	¾	Others
C12N  15/10 200 \	3	3	4B024	C12N  15/10	8	˻ѰͶƳ	Mutagenizing nucleic acids
C12N  15/10 200 P	3	0	4B024	C12N  15/10	264	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/102 is assigned [stop new assigment]
C12N  15/10 200 Z	3	0	4B024	C12N  15/10	1249	¾	Others
C12N  15/10 210 \	4	4	4B024	C12N  15/10	1	ʪ㡥顼ץݥ顼򥳡ɤΡˤ롤ޤϥߥޥåҤ˳ˤ롤ѰͶȯɼǤߥ塼ơѤѰʥΥԽѡãΣ	Mutagenesis using high mutagenic host mutator by inserting a genetic material, e.g. encoding an error prone polymerase, or by disrupting a gene for mismatch repair (Genome Editing Technology, C12N15/09, 100)
C12N  15/10 210 P	4	0	4B024	C12N  15/10	36	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1024 is assigned [stop new assigment]
C12N  15/10 210 Z	4	0	4B024	C12N  15/10	178	¾	Others
C12N  15/10 220 \	4	4	4B024	C12N  15/10	1	ģΣե󥰤ˤΡ㡥ңӣҡӣԣţСңУ	by DNA shuffling, e.g. RsR, sTEP, RPR
C12N  15/10 220 P	4	0	4B024	C12N  15/10	116	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1027 is assigned [stop new assigment]
C12N  15/10 220 Z	4	0	4B024	C12N  15/10	135	¾	Others
C12N  15/10 230 \	4	4	4B024	C12N  15/10	5	ҥ֥ˤѰ㡥ꥴ̥쥪ɥƥ󥷥УãҤˤ륢֥	Mutagenesis by gene assembly, e.g. assembly by oligonucleotide extension PCR
C12N  15/10 230 P	4	0	4B024	C12N  15/10	26	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1031 is assigned [stop new assigment]
C12N  15/10 230 Z	4	0	4B024	C12N  15/10	145	¾	Others
C12N  15/11  \	2	2	4B024	C12N  15/11	171	ģΣޤϣңΣե饰ȡνʪȴѤ˻ѤʤģΣޤϣңΣãȣˡΣ	DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology C07H21/00) [5]
C12N  15/11  P	2	0	4B024	C12N  15/11	1038	ѥƥȥեߥ꡼ˣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/11, C12N15/111 are assigned [stop new assigment]
C12N  15/11  Z	2	0	4B024	C12N  15/11	8309	¾	Others
C12N  15/113  \	3	3	4B024	C12N  15/113	277	ҤȯĴ᤹󥳡ɳ˻㡥󥹥ꥴ̥쥪ɡΣ	Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides [2010.01]
C12N  15/113  P	3	0	4B024	C12N  15/113	1975	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/113 is assigned [stop new assigment]
C12N  15/113  Z	3	0	4B024	C12N  15/113	8452	¾	Others
C12N  15/113 100 \	4	4	4B024	C12N  15/113	10	륹Ф	against viruses
C12N  15/113 100 P	4	0	4B024	C12N  15/113	244	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1131 is assigned [stop new assigment]
C12N  15/113 100 Z	4	0	4B024	C12N  15/113	497	¾	Others
C12N  15/113 102 \	5	5	4B024	C12N  15/113	0	ȥ륹㡥ȣɣ֡Ф	against retroviridae, e.g. HIV
C12N  15/113 102 P	5	0	4B024	C12N  15/113	114	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1132 is assigned [stop new assigment]
C12N  15/113 102 Z	5	0	4B024	C12N  15/113	155	¾	Others
C12N  15/113 104 \	5	5	4B024	C12N  15/113	3	إڥ륹㡥ȣӣ֡Ф	against herpetoviridae, e.g. HsV
C12N  15/113 104 P	5	0	4B024	C12N  15/113	28	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1133 is assigned [stop new assigment]
C12N  15/113 104 Z	5	0	4B024	C12N  15/113	42	¾	Others
C12N  15/113 110 \	4	4	4B024	C12N  15/113	22	ҤޤϴҤФ	against oncogenes or tumor suppressor genes
C12N  15/113 110 P	4	0	4B024	C12N  15/113	340	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1135 is assigned [stop new assigment]
C12N  15/113 110 Z	4	0	4B024	C12N  15/113	688	¾	Others
C12N  15/113 120 \	4	4	4B024	C12N  15/113	1	ĹҡĹĴҡȥ󡤥ۥޤϥۥФ	against growth factors, growth regulators, cytokines, lymphokines or hormones
C12N  15/113 120 P	4	0	4B024	C12N  15/113	333	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1136 is assigned [stop new assigment]
C12N  15/113 120 Z	4	0	4B024	C12N  15/113	568	¾	Others
C12N  15/113 130 \	4	4	4B024	C12N  15/113	19	ǤФΡʥ륹ǣãΣΣãΣ	against enzymes (virus enzymes C12N15/113, 100; receptors C12N15/113, 140)
C12N  15/113 130 P	4	0	4B024	C12N  15/113	767	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1137 is assigned [stop new assigment]
C12N  15/113 130 Z	4	0	4B024	C12N  15/113	1467	¾	Others
C12N  15/113 140 \	4	4	4B024	C12N  15/113	9	ΤޤϺ˦ɽФ	against receptors or cell surface proteins
C12N  15/113 140 P	4	0	4B024	C12N  15/113	644	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/1138 is assigned [stop new assigment]
C12N  15/113 140 Z	4	0	4B024	C12N  15/113	1177	¾	Others
C12N  15/115  \	3	3	4B024	C12N  15/115	50	ץޡʤϥ֥ʳμʤǡðŪˤĹɸŪʬҤ˷礹˻Σ	Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith [2010.01]
C12N  15/115  P	3	0	4B024	C12N  15/115	313	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/115 is assigned [stop new assigment]
C12N  15/115  Z	3	0	4B024	C12N  15/115	2322	¾	Others
C12N  15/117  \	3	3	4B024	C12N  15/117	12	ȱĴͭ˻㡥ãǥդޤ˻Σ	Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs [2010.01]
C12N  15/117  P	3	0	4B024	C12N  15/117	199	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/117 is assigned [stop new assigment]
C12N  15/117  Z	3	0	4B024	C12N  15/117	760	¾	Others
C12N  15/12  \	3	3	4B024	C12N  15/12	18408	ưʪ򥳡ɤҡΣ	Genes encoding animal proteins [5]
C12N  15/13  \	4	4	4B024	C12N  15/13	22531	ȱ֥֥Σ	Immunoglobulins [5]
C12N  15/14  \	4	4	4B024	C12N  15/14	250	ҥȷ֥ߥΣ	Human serum albumins [5]
C12N  15/15  \	4	4	4B024	C12N  15/15	151	ץƥ˳ޡ㡥ȥӥ󡤥ȥץ󡤥ҥ른Σ	Protease inhibitors, e.g. antithrombin, antitrypsin, hirudin [5]
C12N  15/16  \	4	4	4B024	C12N  15/16	615	ۥΣ	Hormones [5]
C12N  15/17  \	5	5	4B024	C12N  15/17	208	󥷥Σ	Insulins [5]
C12N  15/18  \	5	5	4B024	C12N  15/18	140	ĹۥΣ	Growth hormones [5]
C12N  15/19  \	4	4	4B024	C12N  15/19	897	󥿡ե󡨥ۥ󡨥ȥΣ	Interferons; Lymphokines; Cytokines [5]
C12N  15/20  \	5	5	4B024	C12N  15/20	141	󥿡եΣ	Interferons [5]
C12N  15/21  \	6	6	4B024	C12N  15/21	135	󥿡եΣ	Alpha-interferons [5]
C12N  15/22  \	6	6	4B024	C12N  15/22	100	¡󥿡եΣ	Beta-interferons [5]
C12N  15/23  \	6	6	4B024	C12N  15/23	91	á󥿡եΣ	Gamma-interferons [5]
C12N  15/24  \	5	5	4B024	C12N  15/24	1087	󥿡Σ	Interleukins [5]
C12N  15/25  \	6	6	4B024	C12N  15/25	93	󥿡󡽣Σ	Interleukin-1 [5]
C12N  15/26  \	6	6	4B024	C12N  15/26	449	󥿡󡽣Σ	Interleukin-2 [5]
C12N  15/27  \	5	5	4B024	C12N  15/27	176	ˡɷҡΣ	Colony stimulating factors [5]
C12N  15/28  \	5	5	4B024	C12N  15/28	189	ҡΣ	Tumor necrosis factors [5]
C12N  15/29  \	3	3	4B024	C12N  15/29	1375	ʪ㡥ޥ󡤤򥳡ɤҡΣ	Genes encoding plant proteins, e.g. thaumatin [5]
C12N  15/30  \	3	3	4B024	C12N  15/30	176	ưʪ㡥ѷΡ̲¸ꥢͳ򥳡ɤҡΣ	Genes encoding protozoal proteins, e.g. from Plasmodium, Trypanosoma, Eimeria [5]
C12N  15/31  \	3	3	4B024	C12N  15/31	5670	ʪ㡥ƥȥ󡤤򥳡ɤҡΣ	Genes encoding microbial proteins, e.g. enterotoxins [5]
C12N  15/32  \	4	4	4B024	C12N  15/32	62	Х륹ݷ뾽Σ	Bacillus crystal proteins [5]
C12N  15/33  \	4	4	4B024	C12N  15/33	660	륹򥳡ɤҡΣ	Genes encoding viral proteins [5]
C12N  15/34  \	5	5	4B024	C12N  15/34	562	ģΣ륹ͳΣ	Proteins from DNA viruses [5]
C12N  15/35  \	6	6	4B024	C12N  15/35	589	ѥܥ륹ʡ㡥ǭ帺ɥ륹ҥȥѥܥ륹Σ	Parvoviridae, e.g. feline panleukopenia virus, human parvovirus [5]
C12N  15/36  \	6	6	4B024	C12N  15/36	75	إѥɥʥ륹ʡΣ	Hepadnaviridae [5]
C12N  15/37  \	6	6	4B024	C12N  15/37	264	ѥݡХ륹ʡ㡥Ƭ𥦥륹ݥꥪޥ륹ӣ֣Σ	Papovaviridae, e.g. papillomaviruses, polyomavirus, SV40 [5]
C12N  15/38  \	6	6	4B024	C12N  15/38	454	إڥ륹ʡ㡥ñإڥ륹Ӿإڥ륹ץ󡽥С륦륹ȥᥬ륹¥륹Σ	Herpetoviridae, e.g. herpes simplex virus, varicella-zoster virus, Epstein-Barr virus, cytomegalovirus, pseudorabies virus [5]
C12N  15/39  \	6	6	4B024	C12N  15/39	152	ݥå륹ʡ㡥說˥륹쥦륹Σ	Poxviridae, e.g. vaccinia virus, variola virus [5]
C12N  15/40  \	5	5	4B024	C12N  15/40	660	ңΣ륹ͳ㡥եӥ륹Σ	Proteins from RNA viruses, e.g. flaviviruses [5]
C12N  15/41  \	6	6	4B024	C12N  15/41	98	ԥʥ륹ʡ㡥饤Υ륹å륹륹ƥ륹Σ	Picornaviridae, e.g. rhinovirus, coxsackie viruses, echoviruses, enteroviruses [5]
C12N  15/42  \	7	7	4B024	C12N  15/42	46	֥륹Σ	Foot-and-mouth disease virus [5]
C12N  15/43  \	7	7	4B024	C12N  15/43	27	ݥꥪ륹Σ	Poliovirus [5]
C12N  15/44  \	6	6	4B024	C12N  15/44	577	륽ߥ륹ʡ㡥ե륨󥶥륹Σ	Orthomyxoviridae, e.g. influenza virus [5]
C12N  15/45  \	6	6	4B024	C12N  15/45	287	ѥߥ륹ʡ㡥Ϥ륹դ륹˥塼å¥륹ƥѡ륹֥륹쥹ԥȥꥷ󥷥륦륹Σ	Paramyxoviridae, e.g. measles virus, mumps virus, Newcastle disease virus, canine distemper virus, rinderpest virus, respiratory syncytial viruses [5]
C12N  15/46  \	6	6	4B024	C12N  15/46	68	쥪륹ʡ㡥륹֥롼󥰥륹ɥǮ륹Σ	Reoviridae, e.g. rotavirus, bluetongue virus, Colorado tick fever virus [5]
C12N  15/47  \	6	6	4B024	C12N  15/47	141	֥ɥ륹ʡ㡥¥륹ˢꥦ륹Σ	Rhabdoviridae, e.g. rabies viruses, vesicular stomatitis virus [5]
C12N  15/48  \	6	6	4B024	C12N  15/48	174	ȥ륹㡥¥륹ǭ¥륹Σ	Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus [5]
C12N  15/49  \	7	7	4B024	C12N  15/49	411	륹ʡ㡥ȣɣ֡ӥʡޥǥ륹ϴϷ쥦륹ʤɤȱ륹Σ	Lentiviridae, e.g. immunodeficiency viruses such as HIV, visna-maedi virus, equine infectious anaemia virus [5]
C12N  15/50  \	6	6	4B024	C12N  15/50	525	ʥ륹ʡ㡥ɻٱꥦ륹°Ĳꥦ륹Σ	Coronaviridae, e.g. infectious bronchitis virus, transmissible gastroenteritis virus [5]
C12N  15/51  \	5	5	4B024	C12N  15/51	325	αꥦ륹Σ	Hepatitis viruses [5]
C12N  15/52  \	3	3	4B024	C12N  15/52	106	ǤޤϹΤ򥳡ɤҡΣ	Genes encoding for enzymes or proenzymes [5]
C12N  15/52  P	3	0	4B024	C12N  15/52	945	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/52 is assigned [stop new assigment]
C12N  15/52  Z	3	0	4B024	C12N  15/52	1864	¾	Others
C12N  15/53  \	4	4	4B024	C12N  15/53	3502	ԸǡʣˡΣ	Oxidoreductases (1) [5]
C12N  15/54  \	4	4	4B024	C12N  15/54	3844	žܹǡʣˡΣ	Transferases (2) [5]
C12N  15/55  \	4	4	4B024	C12N  15/55	3377	ÿʬǡʣˡΣ	Hydrolases (3) [5]
C12N  15/56  \	5	5	4B024	C12N  15/56	1556	ꥳ벽ʪ˺ѤΡʣˡ㡥ߥ顼饯ȥ꥾Σ	acting on glycosyl compounds (3.2), e.g. amylase, galactosidase, lysozyme [5]
C12N  15/57  \	5	5	4B024	C12N  15/57	1246	ڥץɷ˺ѤΡʣˡΣ	acting on peptide bonds (3.4) [5]
C12N  15/58  \	6	6	4B024	C12N  15/58	45	ץ饹ߥΡҡ㡥ʡԣУΣ	Plasminogen activators, e.g. urokinase, TPA [5]
C12N  15/59  \	6	6	4B024	C12N  15/59	12	⥷Σ	Chymosin [5]
C12N  15/60  \	4	4	4B024	C12N  15/60	1103	ղùǡʣˡΣ	Lyases (4) [5]
C12N  15/61  \	4	4	4B024	C12N  15/61	555	ǡʣˡΣ	Isomerases (5) [5]
C12N  15/62  \	3	3	4B024	C12N  15/62	348	ͻ򥳡ɤģΣΣ	DNA sequences coding for fusion proteins [5]
C12N  15/62  P	3	0	4B024	C12N  15/62	1110	ѥƥȥեߥ꡼ˣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/62, C12N15/625 are assigned [stop new assigment]
C12N  15/62  Z	3	0	4B024	C12N  15/62	15155	¾	Others
C12N  15/63  \	2	2	4B024	C12N  15/63	218	٥ѤʪƳ٥ΤνɼλѡȯΣ	Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression [5]
C12N  15/63  P	2	0	4B024	C12N  15/63	522	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/63 is assigned [stop new assigment]
C12N  15/63  Z	2	0	4B024	C12N  15/63	19681	¾	Others
C12N  15/63 100 \	3	3	4B024	C12N  15/63	3	ͶƳǽʥץåޤϥǥ塼𤷤ȯĴˤäħŤ	Characterized by gene expression regulation via an externally inducible repressor or inducer
C12N  15/63 100 P	3	0	4B024	C12N  15/63	127	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/635 is assigned [stop new assigment]
C12N  15/63 100 Z	3	0	4B024	C12N  15/63	321	¾	Others
C12N  15/64  \	3	3	4B024	C12N  15/64	3	٥¤뤿ᡤ٥˦Ƴ뤿ޤϥ٥ͭɼ򤹤뤿ΰŪˡΣ	General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host [5]
C12N  15/64  P	3	0	4B024	C12N  15/64	191	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/64 is assigned [stop new assigment]
C12N  15/64  Z	3	0	4B024	C12N  15/64	354	¾	Others
C12N  15/65  \	3	3	4B024	C12N  15/65	5	ޡλѡʥޡȤƻѤǣãΣˡΣ	using markers (enzymes used as markers C12N15/52) [5]
C12N  15/65  P	3	0	4B024	C12N  15/65	115	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/65 is assigned [stop new assigment]
C12N  15/65  Z	3	0	4B024	C12N  15/65	310	¾	Others
C12N  15/66  \	3	3	4B024	C12N  15/66	4	ϢȿѤ뤳Ȥˤꡤ٥˰Ҥȴ٥뤿ΰŪˡǽŪ󥫡ޤϥץ㡥¥ɥ̥쥢ǧͭ󥫡λѡΣ	General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease [5]
C12N  15/66  P	3	0	4B024	C12N  15/66	211	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/66 is assigned [stop new assigment]
C12N  15/66  Z	3	0	4B024	C12N  15/66	336	¾	Others
C12N  15/67  \	3	3	4B024	C12N  15/67	5	ȯ뤿ΰŪˡΣ	General methods for enhancing the expression [5]
C12N  15/67  P	3	0	4B024	C12N  15/67	582	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/67 is assigned [stop new assigment]
C12N  15/67  Z	3	0	4B024	C12N  15/67	917	¾	Others
C12N  15/68  \	4	4	4B024	C12N  15/68	1	٥ΰΣ	Stabilisation of the vector [5]
C12N  15/68  P	4	0	4B024	C12N  15/68	79	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/68 is assigned [stop new assigment]
C12N  15/68  Z	4	0	4B024	C12N  15/68	114	¾	Others
C12N  15/69  \	4	4	4B024	C12N  15/69	0	٥ΥԡΣ	Increasing the copy number of the vector [5]
C12N  15/69  P	4	0	4B024	C12N  15/69	90	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/69 is assigned [stop new assigment]
C12N  15/69  Z	4	0	4B024	C12N  15/69	131	¾	Others
C12N  15/70  \	3	3	4B024	C12N  15/70	17	ĲݤäŬ礹٥ޤȯƥΣ	Vectors or expression systems specially adapted for E. coli [5]
C12N  15/70  P	3	0	4B024	C12N  15/70	969	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/70 is assigned [stop new assigment]
C12N  15/70  Z	3	0	4B024	C12N  15/70	1719	¾	Others
C12N  15/71  \	4	4	4B024	C12N  15/71	0	𡽥ڥͳ褹ѤȯƥΣ	Expression systems using regulatory sequences derived from the trp-operon [5]
C12N  15/71  P	4	0	4B024	C12N  15/71	93	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/71 is assigned [stop new assigment]
C12N  15/71  Z	4	0	4B024	C12N  15/71	108	¾	Others
C12N  15/72  \	4	4	4B024	C12N  15/72	0	㡽ڥͳ褹ѤȯƥΣ	Expression systems using regulatory sequences derived from the lac-operon [5]
C12N  15/72  P	4	0	4B024	C12N  15/72	56	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/72 is assigned [stop new assigment]
C12N  15/72  Z	4	0	4B024	C12N  15/72	92	¾	Others
C12N  15/73  \	4	4	4B024	C12N  15/73	0	˥եѤȯƥΣ	Expression systems using phage lambda regulatory sequences [5]
C12N  15/73  P	4	0	4B024	C12N  15/73	91	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/73 is assigned [stop new assigment]
C12N  15/73  Z	4	0	4B024	C12N  15/73	120	¾	Others
C12N  15/74  \	3	3	4B024	C12N  15/74	4	Ĳݰʳθ˽ɼ硤㡥饯ȥХ륹ߥΥݥ顤äŬ礹٥ޤȯƥΣ	Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora [5]
C12N  15/74  P	3	0	4B024	C12N  15/74	378	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/74 is assigned [stop new assigment]
C12N  15/74  Z	3	0	4B024	C12N  15/74	748	¾	Others
C12N  15/74 100 \	4	4	4B024	C12N  15/74	0	Хƥꥦѡ꥾ӥѡ֥ǥ꥾ӥ	for agrobacterium; rhizobium; pradisolium
C12N  15/74 100 P	4	0	4B024	C12N  15/74	11	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/743 is assigned [stop new assigment]
C12N  15/74 100 Z	4	0	4B024	C12N  15/74	53	¾	Others
C12N  15/74 110 \	4	4	4B024	C12N  15/74	2	ѡ㡥ȥץȥå饯ȥå饯ȥХ륹ڥǥåƥå塼Υȥåץԥ˥ХƥꥦࡤӥեɥХƥꥦࡤݥ饯ȥХ륹	for lactic acid bacteria, e.g. streptococcus, lactococcus, lactobacillus, pediococcus, enterococcus, leuconostoc, propionibacterium, bifidobacterium, sporolactobacillus
C12N  15/74 110 P	4	0	4B024	C12N  15/74	103	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/746 is assigned [stop new assigment]
C12N  15/74 110 Z	4	0	4B024	C12N  15/74	145	¾	Others
C12N  15/75  \	4	4	4B024	C12N  15/75	1	Х륹ѡΣ	for Bacillus [5]
C12N  15/75  P	4	0	4B024	C12N  15/75	281	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/75 is assigned [stop new assigment]
C12N  15/75  Z	4	0	4B024	C12N  15/75	388	¾	Others
C12N  15/76  \	4	4	4B024	C12N  15/76	1	ΥߥѡȥץȥߥѡΣ	for Actinomyces; for Streptomyces [5]
C12N  15/76  P	4	0	4B024	C12N  15/76	175	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/76 is assigned [stop new assigment]
C12N  15/76  Z	4	0	4B024	C12N  15/76	199	¾	Others
C12N  15/77  \	4	4	4B024	C12N  15/77	1	ͥХƥꥦѡ֥ӥХƥꥦѡΣ	for Corynebacterium; for Brevibacterium [5]
C12N  15/77  P	4	0	4B024	C12N  15/77	134	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/77 is assigned [stop new assigment]
C12N  15/77  Z	4	0	4B024	C12N  15/77	225	¾	Others
C12N  15/78  \	4	4	4B024	C12N  15/78	0	塼ɥʥѡΣ	for Pseudomonas [5]
C12N  15/78  P	4	0	4B024	C12N  15/78	70	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/78 is assigned [stop new assigment]
C12N  15/78  Z	4	0	4B024	C12N  15/78	106	¾	Others
C12N  15/79  \	3	3	4B024	C12N  15/79	7	˽ɼäŬ礹٥ޤȯƥΣ	Vectors or expression systems specially adapted for eukaryotic hosts [5]
C12N  15/79  P	3	0	4B024	C12N  15/79	152	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/79 is assigned [stop new assigment]
C12N  15/79  Z	3	0	4B024	C12N  15/79	373	¾	Others
C12N  15/80  \	4	4	4B024	C12N  15/80	2	ѡΣ	for fungi [5]
C12N  15/80  P	4	0	4B024	C12N  15/80	330	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/80 is assigned [stop new assigment]
C12N  15/80  Z	4	0	4B024	C12N  15/80	479	¾	Others
C12N  15/81  \	5	5	4B024	C12N  15/81	3	ѡΣ	for yeasts [5]
C12N  15/81  P	5	0	4B024	C12N  15/81	697	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/81 is assigned [stop new assigment]
C12N  15/81  Z	5	0	4B024	C12N  15/81	1056	¾	Others
C12N  15/81 100 \	6	6	4B024	C12N  15/81	0	вʳι	for yeasts other than saccharomyces
C12N  15/81 100 P	6	0	4B024	C12N  15/81	283	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/815 is assigned [stop new assigment]
C12N  15/81 100 Z	6	0	4B024	C12N  15/81	341	¾	Others
C12N  15/82  \	4	4	4B024	C12N  15/82	16	ʪ˦ѡΣ	for plant cells [5]
C12N  15/82  P	4	0	4B024	C12N  15/82	2486	ѥƥȥեߥ꡼ˣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/82, C12N15/8201, C12N15/8202, C12N15/8206, C12N15/8207, C12N15/8209, C12N15/821, C12N15/8212, C12N15/8213, C12N15/8216, C12N15/8218, C12N15/822, C12N15/8221, C12N15/8237, C12N15/8238, C12N15/8239, C12N15/8241, C12N15/8242, C12N15/8243, C12B15/8245, C12N15/8246, C12N15/8247, C12N15/8249, C12N15/8255, C12N15/8257, C12N15/8258, C12N15/8259, C12N15/8261, C12N15/8262, C12N15/8263, C12N15/8265, C12N15/8266, C12N15/8267, C12N15/8269, C12N15/827, C12N15/8287, C12N15/8289, C12N15/829, C12N15/8291, C12N15/8293, C12N15/8294, C12N15/8295, C12N15/8297, C12N15/8298 are assigned [stop new assigment]
C12N  15/82  Z	4	0	4B024	C12N  15/82	2968	¾	Others
C12N  15/82 100 \	5	5	4B024	C12N  15/82	1	ΡߥȥɥꥢηžħΤ	having characteristics in tranforming plastids, mitochondria
C12N  15/82 100 P	5	0	4B024	C12N  15/82	75	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8214 is assigned [stop new assigment]
C12N  15/82 100 Z	5	0	4B024	C12N  15/82	91	¾	Others
C12N  15/82 110 \	5	5	4B024	C12N  15/82	0	ҥåħΤ	having characteristics in gene switch
C12N  15/82 110 P	5	0	4B024	C12N  15/82	53	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8217 is assigned [stop new assigment]
C12N  15/82 110 Z	5	0	4B024	C12N  15/82	63	¾	Others
C12N  15/82 120 \	5	5	4B024	C12N  15/82	0	ȯŪ椵줿ȯƥࡤȿðŪﴱðŪŪޤ϶ŪħΤ	having characteristics in Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
C12N  15/82 120 P	5	0	4B024	C12N  15/82	116	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8222 is assigned [stop new assigment]
C12N  15/82 120 Z	5	0	4B024	C12N  15/82	139	¾	Others
C12N  15/82 122 \	6	6	4B024	C12N  15/82	0	ʪȿðŪץ⡼ħΤ	having characteristics in vegetative tissue-specific promoter
C12N  15/82 122 P	6	0	4B024	C12N  15/82	115	ѥƥȥեߥ꡼ˣãΣãΣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8223, C12N15/8225, C12N15/8226, C12N15/8227, C12N15/8229 are assigned [stop new assigment]
C12N  15/82 122 Z	6	0	4B024	C12N  15/82	179	¾	Others
C12N  15/82 124 \	6	6	4B024	C12N  15/82	0	ȿðŪץ⡼ħΤ	having characteristics in reprodictive tissue-specific promoter
C12N  15/82 124 P	6	0	4B024	C12N  15/82	72	ѥƥȥեߥ꡼ˣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/823, C12N15/8231, C12N15/8233 are assigned [stop new assigment]
C12N  15/82 124 Z	6	0	4B024	C12N  15/82	81	¾	Others
C12N  15/82 126 \	7	7	4B024	C12N  15/82	1	ҡ㡥ðŪʤ	seed-specific, e.g. embryo, endosperm
C12N  15/82 126 P	7	0	4B024	C12N  15/82	77	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8234 is assigned [stop new assigment]
C12N  15/82 126 Z	7	0	4B024	C12N  15/82	96	¾	Others
C12N  15/82 128 \	7	7	4B024	C12N  15/82	0	̼ðŪʤ	fruit-specific
C12N  15/82 128 P	7	0	4B024	C12N  15/82	18	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8235 is assigned [stop new assigment]
C12N  15/82 128 Z	7	0	4B024	C12N  15/82	19	¾	Others
C12N  15/82 130 \	5	5	4B024	C12N  15/82	0	Ǥ˴ؤΡ֤η֤򽤾	related to pigment biosynthesis; modification of flower morphology
C12N  15/82 130 P	5	0	4B024	C12N  15/82	138	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/825 is assigned [stop new assigment]
C12N  15/82 130 Z	5	0	4B024	C12N  15/82	147	¾	Others
C12N  15/82 140 \	5	5	4B024	C12N  15/82	0	ߥλ̤˴ؤΡ㡥¢ߥλϤβ	related to amino acid content, e.g. synthetic storage proteins, altering amino acid biosynthesis
C12N  15/82 140 P	5	0	4B024	C12N  15/82	102	ѥƥȥեߥ꡼ˣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8251, C12N15/8253, C12N15/8254 are assigned [stop new assigment]
C12N  15/82 140 Z	5	0	4B024	C12N  15/82	101	¾	Others
C12N  15/82 150 \	5	5	4B024	C12N  15/82	0	ȥ쥹ΤΤΡ㡥Ŷ°	for stress registance, e.g. heavy metal resistance
C12N  15/82 150 P	5	0	4B024	C12N  15/82	717	ѥƥȥեߥ꡼ˣãΣãΣãΣãΣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8271, C12N15/8279, C12N15/8281, C12N15/8282, C12N15/8283, C12N15/8285, C12N15/8286 are assigned [stop new assigment]
C12N  15/82 150 Z	5	0	4B024	C12N  15/82	745	¾	Others
C12N  15/82 152 \	6	6	4B024	C12N  15/82	1	Фġ䡤ΤΤ	for drought, cold, salt resistance
C12N  15/82 152 P	6	0	4B024	C12N  15/82	148	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8273 is assigned [stop new assigment]
C12N  15/82 152 Z	6	0	4B024	C12N  15/82	157	¾	Others
C12N  15/82 154 \	6	6	4B024	C12N  15/82	0	ΤΤ	for herbicide resistance
C12N  15/82 154 P	6	0	4B024	C12N  15/82	301	ѥƥȥեߥ꡼ˣãΣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8274, C12N15/8275, C12N15/8277, C12N15/8278 are assigned [stop new assigment]
C12N  15/82 154 Z	6	0	4B024	C12N  15/82	337	¾	Others
C12N  15/83  \	5	5	4B024	C12N  15/83	0	륹٥㡥ե⥶륹Σ	Viral vectors, e.g. cauliflower mosaic virus [5]
C12N  15/83  P	5	0	4B024	C12N  15/83	74	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8203 is assigned [stop new assigment]
C12N  15/83  Z	5	0	4B024	C12N  15/83	198	¾	Others
C12N  15/84  \	5	5	4B024	C12N  15/84	0	ԣ顽ץ饹ߥɡΣ	Ti-plasmids [5]
C12N  15/84  P	5	0	4B024	C12N  15/84	177	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8205 is assigned [stop new assigment]
C12N  15/84  Z	5	0	4B024	C12N  15/84	219	¾	Others
C12N  15/85  \	4	4	4B024	C12N  15/85	30	ưʪ˦ѡΣ	for animal cells [5]
C12N  15/85  P	4	0	4B024	C12N  15/85	2649	ѥƥȥեߥ꡼ˣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/85, C12N15/8509, C12N15/8518, C12N15/8527, C12N15/8536, C12N15/8545, C12N15/8554, C12N15/8563, C12N15/8572, C12N15/8581, C12N15/859 are assigned [stop new assigment]
C12N  15/85  Z	4	0	4B024	C12N  15/85	4990	¾	Others
C12N  15/86  \	5	5	4B024	C12N  15/86	38	륹٥Σ	Viral vectors [5]
C12N  15/86  P	5	0	4B024	C12N  15/86	2435	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/86 is assigned [stop new assigment]
C12N  15/86  Z	5	0	4B024	C12N  15/86	4742	¾	Others
C12N  15/861  \	6	6	4B024	C12N  15/861	29	ǥΥ륹٥Σ	Adenoviral vectors [7]
C12N  15/861  P	6	0	4B024	C12N  15/861	18	ѥƥȥեߥ꡼ˣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/861, C12N15/8613, C12N15/8616 are assigned [stop new assigment]
C12N  15/861  Z	6	0	4B024	C12N  15/861	1649	¾	Others
C12N  15/863  \	6	6	4B024	C12N  15/863	7	ݥå륹٥㡥說˥륹Σ	Poxviral vectors, e.g. vaccinia virus [7]
C12N  15/863  P	6	0	4B024	C12N  15/863	4	ѥƥȥեߥ꡼ˣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/863, C12N15/8633, C12N15/8636 are assigned [stop new assigment]
C12N  15/863  Z	6	0	4B024	C12N  15/863	477	¾	Others
C12N  15/864  \	6	6	4B024	C12N  15/864	13	ѥܥ륹٥Σ	Parvoviral vectors [7]
C12N  15/864  P	6	0	4B024	C12N  15/864	2	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/864 is assigned [stop new assigment]
C12N  15/864  Z	6	0	4B024	C12N  15/864	109	¾	Others
C12N  15/864 100 \	7	7	4B024	C12N  15/864	31	ǥοȼ륹٥	Adeno-associated viral vector
C12N  15/864 100 P	7	0	4B024	C12N  15/864	11	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/8645 is assigned [stop new assigment]
C12N  15/864 100 Z	7	0	4B024	C12N  15/864	3240	¾	Others
C12N  15/866  \	6	6	4B024	C12N  15/866	3	Х륹٥Σ	Baculoviral vectors [7]
C12N  15/866  P	6	0	4B024	C12N  15/866	1	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/866 is assigned [stop new assigment]
C12N  15/866  Z	6	0	4B024	C12N  15/866	271	¾	Others
C12N  15/867  \	6	6	4B024	C12N  15/867	27	ȥ륹٥Σ	Retroviral vectors [7]
C12N  15/867  P	6	0	4B024	C12N  15/867	11	ѥƥȥեߥ꡼ˣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/867, C12N15/8673, C12N15/8676 are assigned [stop new assigment]
C12N  15/867  Z	6	0	4B024	C12N  15/867	2442	¾	Others
C12N  15/869  \	6	6	4B024	C12N  15/869	6	إڥ륹٥Σ	Herpesviral vectors [7]
C12N  15/869  P	6	0	4B024	C12N  15/869	4	ѥƥȥեߥ꡼ˣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/869, C12N15/8695 are assigned [stop new assigment]
C12N  15/869  Z	6	0	4B024	C12N  15/869	612	¾	Others
C12N  15/87  \	2	2	4B024	C12N  15/87	10	¾ʬवʤˡѤʪƳ㡥ƱžΣ	Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation [5]
C12N  15/87  P	2	0	4B024	C12N  15/87	665	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/87 is assigned [stop new assigment]
C12N  15/87  Z	2	0	4B024	C12N  15/87	1582	¾	Others
C12N  15/873  \	3	3	4B024	C12N  15/873	5	¤뤿εѡ㡥˰ܿǽ˦Υޥ˥ԥ졼󡤤ޤϡ¤Σ	Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos [2010.01]
C12N  15/873  P	3	0	4B024	C12N  15/873	91	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/873 is assigned [stop new assigment]
C12N  15/873  Z	3	0	4B024	C12N  15/873	261	¾	Others
C12N  15/877  \	4	4	4B024	C12N  15/877	1	Ӯưʪ¤뤿εѡΣ	Techniques for producing new mammalian cloned embryos [2010.01]
C12N  15/877  P	4	0	4B024	C12N  15/877	83	ѥƥȥեߥ꡼ˣãΣãΣãΣãΣãΣãΣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/877, C12N15/8771, C12N15/8772, C12N15/8773, C12N15/8775, C12N15/8776, C12N15/8777, C12N15/8778 are assigned [stop new assigment]
C12N  15/877  Z	4	0	4B024	C12N  15/877	227	¾	Others
C12N  15/88  \	3	3	4B024	C12N  15/88	16	ޥץ벽ѤΡ㡥ݥྮ˦ѤΡΣ	using microencapsulation, e.g. using liposome vesicle [5]
C12N  15/88  P	3	0	4B024	C12N  15/88	276	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/88 is assigned [stop new assigment]
C12N  15/88  Z	3	0	4B024	C12N  15/88	1514	¾	Others
C12N  15/89  \	3	3	4B024	C12N  15/89	2	ޥ󥸥ˡѤΡΣ	using microinjection [5]
C12N  15/89  P	3	0	4B024	C12N  15/89	67	ѥƥȥեߥ꡼ˣãΣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/89, C12N15/895 are assigned [stop new assigment]
C12N  15/89  Z	3	0	4B024	C12N  15/89	194	¾	Others
C12N  15/90  \	3	3	4B024	C12N  15/90	6	ģΣؤΰƳΣ	Stable introduction of foreign DNA into chromosome [5]
C12N  15/90  P	3	0	4B024	C12N  15/90	229	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/90 is assigned [stop new assigment]
C12N  15/90  Z	3	0	4B024	C12N  15/90	484	¾	Others
C12N  15/90 100 \	4	4	4B024	C12N  15/90	6	ƱȴѤΡʥΥԽѡ㡥ԣ̣ţΡ󥯥ե󥬡̥쥢ѤΣãΣãңɣӣУҡãѤΣãΣ	using homologous recombination (using genome editing technology, e.g. C12N15/09, 100 for use of TALEN, zinc finger nuclease; C12N15/09, 110 for use of CRIsPR/Cas)
C12N  15/90 100 P	4	0	4B024	C12N  15/90	138	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/902 is assigned [stop new assigment]
C12N  15/90 100 Z	4	0	4B024	C12N  15/90	427	¾	Others
C12N  15/90 102 \	5	5	4B024	C12N  15/90	0	ˤ	in yeast
C12N  15/90 102 P	5	0	4B024	C12N  15/90	30	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/905 is assigned [stop new assigment]
C12N  15/90 102 Z	5	0	4B024	C12N  15/90	80	¾	Others
C12N  15/90 104 \	5	5	4B024	C12N  15/90	1	Ӯ˦ˤ	in mammalian cells
C12N  15/90 104 P	5	0	4B024	C12N  15/90	258	ѥƥȥեߥ꡼ˣãΣΣãУäͿƤΡڿͿߡ	for patent family with CPC C12N15/907 is assigned [stop new assigment]
C12N  15/90 104 Z	5	0	4B024	C12N  15/90	413	¾	Others
